TickerFacts.

Company research / CMMB

Chemomab Therapeutics Ltd. (CMMB)

Build a valuation ↗↓ Download CSV

CIK 0001534248 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

Key ratios (year ended 2025-12-31)

-72.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Cost of Revenue$2.33M$2.46M$4.39M$5.14M$3.31Mn/an/an/a
R&D Expense$5.83M$11.33M$18.38M$16.98M$6.33M$4.68M$13.30M$7.51M
Operating Income-$112.00M-$103.00Mn/an/an/an/an/an/a
Net Income-$8.99M-$13.95M-$24.22M-$27.65M-$12.48M-$5.95M-$27.12M-$13.80M
EPS (Diluted)$0.018$0.039$0.10$0.12$0.06n/an/an/a
Total Assets$13.81M$16.96M$22.15M$43.06M$64.35M$12.48M$19.75M$12.76M
Total Liabilities$1.48M$3.43M$5.15M$6.84M$2.89M$1.67M$4.85M$2.96M
Shareholders' Equity$12.33M$13.54M$17.00M$36.22M$61.47M$10.80M$14.91M$9.80M
Cash & Equivalents$7.56M$6.07M$9.29M$13.52M$15.19M$11.67M$17.57M$7.52M
Operating Cash Flow-$11.13M-$15.39M-$23.61M-$20.37M-$12.37M-$5.24M-$16.46M-$14.22M
Capital Expenditures$3.0K$0$3.0K$68.0K$239.0K$38.0K$95.0K$213.0K
Free Cash Flow-$11.13M-$15.39M-$23.61M-$20.44M-$12.61M-$5.28M-$16.55M-$14.44M
Shares Outstandingn/an/an/an/an/a37.10M37.10M15.58M
Weighted Average Diluted Shares510.23M359.05M235.00M227.59M207.47Mn/an/an/a
EPS (Basic)$0.018$0.039$0.10$0.12$0.06n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView